ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 274,48
-0,27%
Dow Jones
42 840,26
1,18%
DAX
19 884,75
-0,57%
Brent Oil
72,72
0,00%
Bitcoin
97 419,36
-0,35%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Dogwood Therapeutics Inc (DWTX) Cours

Dogwood Therapeutics Inc

Dogwood Therapeutics Inc (DWTX)

NASDAQ
2,34
0,02
(0,86%)
Fermé 21 Décembre 10:00PM
Retardé de 15 minutes
2,34
0,00
(0,00%)
Après les heures de négociation: 11:06PM
Retardé de 15 minutes

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Statistiques et détails clés

Dernier
2,34
Prix Achat
2,31
Prix Vente
23,10
Volume échangé
33 399
2,30 Fourchette du Jour 2,63
1,62 Plage de 52 semaines 5,29
Clôture Veille
2,32
Ouverture
2,30
Dernière Transaction
1
@
2.49
Dernière heure de transaction
Volume moyen (3 m)
92 130
Volume financier
US$ 80 823
VWAP
2,4199

DWTX Dernières nouvelles

Plus de nouvelles

Dogwood Therapeutics, Inc. Announces Low Dose IMC-2 Treatment Reduces Long-COVID Related Fatigue and Sleep Disturbance in an Investigator-Initiated Study

- IMC-2 treatment, dosed as valacyclovir 750 mg + celecoxib 200 mg twice daily, demonstrated clinically meaningful reduction in Long-COVID related fatigue and sleep disturbance as compared to...

18 Novembre 2024
GlobeNewswire Inc.

Dogwood Therapeutics Announces Third Quarter 2024 Financial Results

- Dogwood Therapeutics, Inc. (Nasdaq: “DWTX”) formed in October by combination of Virios Therapeutics, Inc. and Pharmagesic (Holdings) Inc., 100% parent company of Wex Pharmaceuticals, Inc. (the...

07 Novembre 2024
GlobeNewswire Inc.

Dogwood Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update on Thursday, November 7, 2024

ATLANTA, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the “Company”), formerly Virios Therapeutics, Inc., a clinical‐stage biopharmaceutical company, announced...

31 Octobre 2024
GlobeNewswire Inc.

Dogwood Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement

ATLANTA, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the “Company”), formerly Virios Therapeutics, Inc., a clinical‐stage biopharmaceutical company, announced...

30 Octobre 2024
GlobeNewswire Inc.

Virios Therapeutics, Inc. and Wex Pharmaceuticals, Inc. Announce Business Combination to Form Dogwood Therapeutics, Inc. (Nasdaq: “DWTX”)

Strategic financing by an affiliate of CK Life Sciences Int’l., (Holdings) Inc., results in working capital of approximately $23 million to fund operations and advance Phase 2b Halneuron®...

07 Octobre 2024
GlobeNewswire Inc.
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.1118-4.559915164372.45182.65712.3066121172.39832252CS
4-0.26-102.62.872.29238512.50168235CS
12-1.21-34.08450704233.555.291.62921303.56164515CS
26-1.21-34.08450704233.555.291.62921303.56164515CS
52-1.21-34.08450704233.555.291.62921303.56164515CS
156-1.21-34.08450704233.555.291.62921303.56164515CS
260-1.21-34.08450704233.555.291.62921303.56164515CS

DWTX - Frequently Asked Questions (FAQ)

What is the current Dogwood Therapeutics share price?
The current share price of Dogwood Therapeutics is US$ 2,34
What is the 1 year trading range for Dogwood Therapeutics share price?
Dogwood Therapeutics has traded in the range of US$ 1,62 to US$ 5,29 during the past year

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
MYSZMy Size Inc
US$ 4,2001
(211,12%)
120,01M
NVNINVNI Group Ltd
US$ 8,26
(209,36%)
76,64M
TPICTPI Composites Inc
US$ 2,45
(100,82%)
33,95M
ICGIntchains Group Ltd
US$ 8,77
(88,60%)
527,61k
HSDTHelius Medical Technologies Inc
US$ 0,884851
(84,34%)
120,4M
CYNCYNGN Inc
US$ 0,4603
(-71,41%)
27,91M
MTEMMolecular Templates Inc
US$ 0,1502
(-57,09%)
8,75M
PRFXPainReform Ltd
US$ 5,15
(-53,85%)
2,94M
GALTGalectin Therapeutics Inc
US$ 1,03
(-48,50%)
9,27M
BCABBioAtla Inc
US$ 0,6923
(-41,82%)
6,25M
EDBLEdible Garden AG Inc
US$ 0,24
(65,06%)
354,32M
APTOAptose Biosciences Inc
US$ 0,28
(64,51%)
305,1M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,606999
(6,49%)
292,16M
NVDANVIDIA Corporation
US$ 134,70
(3,08%)
287,21M
PLTRPalantir Technologies Inc
US$ 80,55
(8,54%)
277,63M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
DWTX
Dogwood Therapeutics
COIN
AETHHETH
Aave Interest bearing ETH
COIN
ARWWKRW
Arowana Token
COIN
ARNETH
Aeron
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés